< Zurück zu den wissenschaftlichen Publikationen

Magazin 2.21

Social cognition deficit and genetic vulnerability to schizophrenia in 22q11 deletion syndrome.

Autoren: Frascarelli M, Padovani G, Buzzanca A, Accinni T, Carlone L, Ghezzi F, Lattanzi GM, Fanella M, Putotto C, Di Bonaventura C, Girardi N, Pasquini M, Biondi M, Di F.

Datum: 2020

Interessensgebiet: Psychiatrische Störungen/seltene Erkrankungen




Das könnte Sie auch interessieren:

Magazin 10,859

Tighter glycemic control is associated with ADL physical dependency losses in older patients using sulfonylureas or mitiglinides: Results from the DIMORA STUDY

Autoren: Abbatecola AM, Bo M, Armellini F, D'Amico F, Desideri G, Falaschi P, Greco A, Guerrini G, Lattanzio F, Volpe C, Paolisso G

Datum: 2015

Interessensgebiet: stoffwechsel, Diabetes


Details lesen
Magazin 5,1

Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors

Autoren: Benedetta Stefanini et al

Datum: 22. November 2023

Interessensgebiet: hepatologisch


Details lesen
Magazin

The efficacy of CHOEP chemotherapyregimenadministered in association with monoclonalantibody anti-CD52 Alemtuzumab in cutaneous T-celllymphoma (CTCL) and systemic T-celllymphoma with cutaneousinvolvement (PTCL)

Autoren: Postorino M, De Santis G, Marchesi F, Provenzano I, Franceschini L, Pupo L, Rizzo M, Giannì L, Gumenyuk S, Tonialini L, Fiorelli E, Renzi D, Zizzari A.

Datum: 2013

Interessensgebiet: Hämatologie


Details lesen